Wakamoto announces Japanese phase III trial of WP-1303 for glaucoma and ocular hypertension Dec. 4, 2018 No Comments
FDA clears IND for first-in-human trial of QR-421a in patients with Usher syndrome type 2 Dec. 4, 2018 No Comments
Preclinical data support potential of CAP-1160 for treatment and prevention of cataracts Dec. 4, 2018 No Comments
The Warner Babcock Institute for Green Chemistry patents beta-amyloid inhibitors Nov. 30, 2018 No Comments
European Commission approves Luxturna for RPE65 mutation-associated retinal dystrophy Nov. 23, 2018 No Comments
First patients dosed in phase I OPTIC study of ADVM-022 gene therapy in wet AMD Nov. 20, 2018 No Comments
Nightstar Therapeutics updates status of NSR-RPGR program in X-linked retinitis pigmentosa Nov. 13, 2018 No Comments
RSS